These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11796387)

  • 1. Impact of trimethoprim-sulfamethoxazole prophylaxis on etiology and susceptibilities of pathogens causing human immunodeficiency virus-associated bacteremia.
    Wininger DA; Fass RJ
    Antimicrob Agents Chemother; 2002 Feb; 46(2):594-7. PubMed ID: 11796387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole.
    Edge MD; Rimland D
    AIDS; 1996 Dec; 10(14):1635-9. PubMed ID: 8970683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thresholds of CD4 cells for initiating trimethoprim-sulfamethoxazole prophylaxis in west Africa.
    Anglaret X; Toure S; Ouassa T; Dabis F; N'Dri-Yoman T
    AIDS; 2000 Nov; 14(16):2628-9. PubMed ID: 11101085
    [No Abstract]   [Full Text] [Related]  

  • 4. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.
    Martin JN; Rose DA; Hadley WK; Perdreau-Remington F; Lam PK; Gerberding JL
    J Infect Dis; 1999 Dec; 180(6):1809-18. PubMed ID: 10558935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania.
    Morpeth SC; Thielman NM; Ramadhani HO; Hamilton JD; Ostermann J; Kisenge PR; Shao HJ; Reller LB; Itemba DK; Sam NE; Bartlett JA; Shao JF; Crump JA
    J Acquir Immune Defic Syndr; 2008 Apr; 47(5):585-91. PubMed ID: 18285712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
    Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
    J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.
    Esposito S; Bojanin J; Porta A; Cesati L; Gualtieri L; Principi N
    Pediatr Infect Dis J; 2005 Dec; 24(12):1117-20. PubMed ID: 16371882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-Dependent Hyperkalemia Among Hospitalized, HIV-Infected Patients Receiving Sulfamethoxazole/Trimethoprim.
    Caulder CR; Kocherla CS; Qureshi ZP; Magagnoli J; Bookstaver PB
    Ann Pharmacother; 2020 Sep; 54(9):852-857. PubMed ID: 32106685
    [No Abstract]   [Full Text] [Related]  

  • 9. Community-acquired bacteremia in human immunodeficiency virus-infected children in Harare, Zimbabwe.
    Nathoo KJ; Chigonde S; Nhembe M; Ali MH; Mason PR
    Pediatr Infect Dis J; 1996 Dec; 15(12):1092-7. PubMed ID: 8970218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening method for trimethoprim/sulfamethoxazole-resistant small colony variants of Staphylococcus aureus.
    Sato T; Kawamura M; Furukawa E; Fujimura S
    J Glob Antimicrob Resist; 2018 Dec; 15():1-5. PubMed ID: 29857058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of HIV infection and trimethoprim-sulphamethoxazole prophylaxis on bacterial isolates from children with community-acquired pneumonia in South Africa.
    Zar HJ; Hanslo D; Hussey G
    J Trop Pediatr; 2003 Apr; 49(2):78-83. PubMed ID: 12729288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of opportunistic infections in HIV infection].
    Pesce A
    Rev Med Interne; 1995; 16 Suppl 3():315s-319s. PubMed ID: 8570970
    [No Abstract]   [Full Text] [Related]  

  • 13. Pneumocystis carinii pneumonia after cessation of secondary prophylaxis in a patient on highly active antiretroviral therapy with a CD4 cell count greater than 200/mm3.
    Lim L ; Street AC; Lewin SR
    AIDS; 2001 Sep; 15(14):1912-3. PubMed ID: 11579267
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterogeneity of antimicrobial susceptibility testing results for sulfamethoxazole/trimethoprim obtained from clinical equine Staphylococcus aureus isolates using different methods.
    Scholtzek AD; Hanke D; Eichhorn I; Walther B; Lübke-Becker A; van Duijkeren E; Köck R; Schwarz S; Feßler AT
    Vet Microbiol; 2020 Mar; 242():108600. PubMed ID: 32122605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of co-trimoxazole for urinary tract infections in developing countries.
    Leblebicioglu H; Ozaras R; Sunbul M
    Lancet Infect Dis; 2015 Jul; 15(7):764-5. PubMed ID: 26122444
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of trimethoprim-sulphamethoxazole in preventing HIV-associated bacteraemia.
    Tumbarello M; Tacconelli E; Cauda R; Ortona L
    AIDS; 1997 Jul; 11(8):1070-1. PubMed ID: 9223752
    [No Abstract]   [Full Text] [Related]  

  • 17. [Severe bacterial infections after prophylactic suppression of Pneumocystis carinii in HIV infected patients after CD4 lymphocyte recovery].
    Boix V; Murcia JM; Merino E; Portilla J
    Med Clin (Barc); 2002 Jun; 118(20):796-7. PubMed ID: 12049699
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection.
    DiRienzo AG; van Der Horst C; Finkelstein DM; Frame P; Bozzette SA; Tashima KT
    AIDS Res Hum Retroviruses; 2002 Jan; 18(2):89-94. PubMed ID: 11839141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus.
    Smith CL; Brown I; Torraca BM
    Clin Infect Dis; 1997 Dec; 25(6):1477-8. PubMed ID: 9431404
    [No Abstract]   [Full Text] [Related]  

  • 20. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial.
    Verdier RI; Fitzgerald DW; Johnson WD; Pape JW
    Ann Intern Med; 2000 Jun; 132(11):885-8. PubMed ID: 10836915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.